Nyxoah Raises $110 Million to Accelerate US Launch of Genio Sleep Apnea Device

MT Newswires Live
06/11

Nyxoah (NYXH) secured $110 million in new capital to support the US commercial rollout of its Genio sleep apnea treatment system, the medical technology company said late Wednesday.

The company completed a $95 million equity financing and expects to receive the second $15 million tranche of its European Investment Bank loan by the end of June.

Nyxoah said the funding will help accelerate the commercialization of Genio in the US, where it has built a sales force of 40 representatives following the device's US Food and Drug Administration approval in 2025.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10